About CaptiGen
CaptiGen is a company based in Philadelphia (United States) founded in 2018 was acquired by MicroGen Diagnostics in April 2022. CaptiGen operates in a competitive market with competitors including Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
- Headquarter Philadelphia, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website captigen.net
- Social X Facebook Instagram
- Acquired by MicroGen Diagnostics (Apr 2022)
- Investors
- Acquired byMicroGen Diagnostics
(Apr 2022)
Investors in CaptiGen
CaptiGen has secured backing from 1 investor. Prominent investors backing the company include MicroGen Diagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sequencing and molecular diagnostic services are provided for microbial detection. | 2011 | microgendx.com | Orlando, United States |
Investor details for CaptiGen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CaptiGen
2 dated milestones of CaptiGen across 4 years, from founding to its latest funding, stage changes and deals.
- Founded CaptiGen is founded.
- Exit Acquired by MicroGen Diagnostics.
Competitors of CaptiGen
CaptiGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| prenetics.com | 2009 | Hong Kong, China | $67.65M | – | Health risks are identified through online genetic and diagnostic testing. | |
| opgen.com | 2002 | Rockville, United States | $77.51M | 100 | Developer of diagnostics and bioinformatics platforms for providers | |
| dayzerodiagnostics.com | 2016 | Boston, United States | $48.6M | 48 | Genome sequencing diagnostics for infectious diseases are developed. | |
| clearlabs.com | 2014 | Menlo Park, United States | $171.09M | 55 | Food safety technologies are provided for pathogen identification. | |
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| curetis.com | 2007 | Holzgerlingen, Germany | $127.14M | 55 | Molecular diagnostics platform is provided for infectious disease detection. | |
| seegene.com | 2000 | Seoul, South Korea | – | – | Developer of molecular diagnostic kits to detect infectious and genetic diseases | |
| pathoquest.com | 2010 | Paris, France | $9.99M | – | Next-generation sequencing is provided for microbiology testing applications. | |
| springbankpharm.com | 2002 | Milford, United States | $36.7M | 84 | Viral infection treatments are developed using nucleic acid hybrid chemistry. |
Detailed competitors of CaptiGen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Captigen
Complete news archive for CaptiGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to CaptiGen
10 companies that operate in the same segment as CaptiGen (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CaptiGen
CaptiGen was founded in 2018.
CaptiGen is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
CaptiGen was founded in 2018 in Philadelphia, United States, within the biotechnology sector. A precision microbial sampling device known as AptiSwab has been developed to enhance culture yield, RT-PCR yield, and next-generation sequencing outcomes. Environmental and food samples are tested using this technology. Operations focus on advancing sampling methods for laboratory and diagnostic applications.
CaptiGen's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
CaptiGen has 1 investor. Key investors include MicroGen Diagnostics.
Yes. CaptiGen was acquired by MicroGen Diagnostics in April 2022.